Updated

Scientists have developed an experimental injection that causes fat cells to self-destruct, significantly reducing dangerous belly fat in early research and potentially offering a new treatment avenue for obesity. The approach may also help prevent the weight regain often seen after patients stop taking GLP-1 drugs like Ozempic and Wegovy. The findings are preliminary but suggest a complementary or alternative strategy to existing pharmaceutical weight-loss treatments.